Modulation of erm methyltransferase activity by peptides derived from phage display

Area of Science:

• Biochemistry
• Molecular Biology
• Enzymology

Background:

• ErmC' methyltransferase from Bacillus subtilis plays a role in antibiotic resistance.
• Understanding methyltransferase inhibition is crucial for developing new antimicrobial strategies.

Purpose of the Study:

• To identify novel peptide inhibitors of ErmC' methyltransferase using phage display.
• To characterize the inhibitory mechanism and specificity of identified peptides.

Main Methods:

• Combinatorial peptide display technology utilizing phage M13 protein pIII.
• In vitro enzymatic assays to determine inhibitory concentrations (IC50).
• Comparative analysis of peptide activity against homologous methyltransferases.

Main Results:

• A specific peptide, Ac-LSGVIAT-NH(2), was identified that selectively binds to ErmC'.
• This peptide demonstrated in vitro inhibition of ErmC' methylation with an IC50 of 20 microM.
• The identified peptides that inhibited ErmC' also stimulated ErmSF, a related enzyme.

Conclusions:

• Ac-LSGVIAT-NH(2) may inhibit ErmC' through allosteric modulation rather than direct catalytic site binding.
• The findings suggest a potential new mechanism for targeting methyltransferases.
• This research opens avenues for developing novel inhibitors for antibiotic resistance mechanisms.